Sally Church, PhD has been included in the FierceBiotech Top Voices in Biotech Twittersphere published today.
It is always good to receive recognition of Sally’s expertise in cancer drug development and the way she actively engages in social media (Sally writes as @MaverickNY on Twitter).
The Biotech Twittersphere is a community we are pleased to be part of. It’s where information is shared and discussions take place in real-time about new clinical trial results, and the impact for patients and companies. Sally is widely regarded as an industry expert in oncology/hematology new product development and commercialization.
Thanks FierceBiotech for the recognition!